Healthcare decisions are often delayed by the time required to identify infectious pathogens and determine the most appropriate treatment. Scientists at Sticky Ends Bio is developing innovative molecular diagnostic solutions that make infectious disease testing faster, more accessible, and suitable for decentralized healthcare settings.
Our pipeline enables rapid detection of clinically important pathogens with actionable information for evidence-based treatment decisions. Designed for hospitals, diagnostic labs, primary healthcare centers, and resource-limited settings.
Innovating Molecular Diagnostics for Faster Healthcare Decisions
Key Focus Areas
Antimicrobial Resistance
Developing solutions for early identification of clinically significant pathogens.
Point-of-Care Diagnostics
Supporting informed antibiotic selection through rapid molecular testing.
Rapid Infectious Disease Detection
Designed with accessibility and ease of deployment as key objectives.
Public Health & Surveillance
Enabling data-driven disease monitoring and antimicrobial stewardship.
Our products are currently under active research and development, progressing through research, validation, and regulatory pathways before clinical deployment. We collaborate with researchers, clinicians, and healthcare institutions to translate laboratory innovations into real-world diagnostic solutions.
Interested in Collaborating?
Development Status
Whether you are a researcher, diagnostic lab manager, or industry partner, we welcome conversations about research partnerships and collaboration opportunities.
STICKY ENDS BIO PRIVATE LIMITED
Building No: 446, Mangattuparamba, Kalliasseri, Kannur University Campus, Kannur, Kerala, India, 670567
© Sticky Ends Bio Pvt. Ltd. All rights reserved.
stickyendsbio@gmail.com
+91 860 66 88 99 4
CIN: U74909KL2025PTC096927
